Infectious Diseases News and Research

RSS

Genetic mutations in parasite cause over 100 million cases of malaria annually in Africa

Researchers at Case Western Reserve University and Cleveland Clinic Lerner Research Institute have discovered recent genetic mutations in a parasite that causes over 100 million cases of malaria annually-changes that may render tens of millions of Africans who had been considered resistant, susceptible to infection.

16 Nov 2013

Mass. Eye and Ear's OGSH launches new collaboration to care for people ENT diseases

Rates of death and disability stemming from ear, nose and throat conditions continue to rise in developing countries like Uganda, but despite the need, fewer than 15 operating ear, nose and throat surgeons serve Uganda's 33.4 million and growing population. Only two ENT residency programs exist in this country, but many trainees do not remain in the country after graduation. Mass. Eye and Ear's Office of Global Surgery and Health is launching a new collaboration with Mbarara University Science and Technology School of Medicine and Mbarara Regional Referral Hospital to help address the need for more trained physicians to care for the ENT diseases and conditions of this population and to help encourage those who are ENT trained to stay in the country to care for those who need them.

16 Nov 2013

New Malaria Vaccine Technology Roadmap aims to identify second generation malaria vaccines

The world should aim to have vaccines which reduce malaria cases by 75%, and are capable of eliminating malaria, licensed by 2030, according to the updated 2013 "Malaria Vaccine Technology Roadmap", launched today.

15 Nov 2013

Scientists identify genetic signature of respiratory syncytial virus

Scientists have identified the genetic signature of respiratory syncytial virus, the leading cause of infant hospitalizations around the world. The work is a key step toward a better understanding of the immune response to RSV, which will aid the development of a vaccine and a tool that could allow physicians to determine the severity of the infection when symptoms first develop. The study, from a team at The Research Institute at Nationwide Children's Hospital, was published this week in PLOS Medicine.

15 Nov 2013

Lower doses of antimalarial drug effective in reducing malaria transmission

Lower doses of the antimalarial drug primaquine are as effective as higher doses in reducing malaria transmission, according to a study published today in Lancet Infectious Diseases by London School of Hygiene & Tropical Medicine researchers.

15 Nov 2013

$Research may explain why people who take bone-strengthening drugs are at-risk for atypical fractures$

Research may explain why people who take bone-strengthening drugs are at-risk for atypical fractures

Research with baboons at the Texas Biomedical Research Institute may help explain why some people who take bone-strengthening drugs like bisphosphonates are at-risk for atypical fractures in the long bones in their legs.

15 Nov 2013

HIVMA's updated HIV care guidelines show doctors should focus on common health conditions

The HIV Medicine Association of the Infectious Diseases Society of America has updated its HIV care guidelines to reflect the fact that people with HIV are now living normal life spans, and their physicians need to focus on preventive care, including screening for high cholesterol, diabetes and osteoporosis.

15 Nov 2013

Identifying 'sensome' of microglia could improve treatments for neurodegenerative disorders

Massachusetts General Hospital investigators have used a new sequencing method to identify a group of genes used by the brain's immune cells - called microglia - to sense pathogenic organisms, toxins or damaged cells that require their response.

15 Nov 2013

Dermalogix awarded SBIR Phase II grant to develop topical drug candidate for atopic dermatitis

Signum Dermalogix, Inc. announced that the National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded the company a Small Business Innovation Research Phase II grant totaling $1.6 million for the development of a topical drug candidate for atopic dermatitis.

15 Nov 2013

Diagnosing influenza with rapid tests leads to more efficient care

When patients in the emergency department (ED) are diagnosed with influenza by means of a rapid test, they get fewer unnecessary antibiotics, are prescribed antiviral medications more frequently, and have fewer additional lab tests compared to patients diagnosed with influenza without testing, according to a new study. Published online in the Journal of the Pediatrics Infectious Diseases Society, the findings suggest that diagnosing influenza with a rapid diagnostic test leads to more appropriate, specific, and efficient care.

14 Nov 2013

TAILORED-Treatment project to increase effectiveness of antibiotics receives EU funding

The European Union has funded a 4 year project called TAILORED-Treatment with € 6.000.000,-. The main goal of TAILORED -Treatment is to establish a strategy that can be used to increase the effectiveness of antibiotic treatment, reduce any potential side-effects of therapy, and help limit the emergence of antimicrobial resistance in hospitalized children and adults. The project will be coordinated by Erasmus MC, Rotterdam, the Netherlands.

14 Nov 2013

immatics, Roche enter into cancer vaccine and immunotherapy deal

immatics biotechnologies GmbH and Roche today announced a strategic research and development collaboration covering multiple cancer vaccines and immunotherapeutics.

13 Nov 2013

New biomedical instrument anticipated to help breakthroughs in animal, human health

A Kansas State University team recently received a nearly $1.3 million grant from the National Science Foundation's Major Research Institute for a biomedical instrument that is anticipated to help with breakthroughs in animal and human health as well as cancer treatment.

13 Nov 2013

Infection prevention: an interview with Dr. Robert Gorab, Chief Medical Officer, Hoag Orthopedic Institute

HOI has one of the lowest if not the lowest surgical readmission rate in the State of California. Our all-cause readmission rate is 3.3% and our joint replacement readmission was at 1.8% based on published CMS reports we received in September 2013.

12 Nov 2013

Researchers discover new pathway for treating allergic diseases

A collaboration among researchers in Israel and the United States has resulted in the discovery of a new pathway that has broad implications for treating allergic diseases - particularly eosinophil-associated disorders.

12 Nov 2013

Researchers find zinc starves bacteria by preventing its uptake of essential metal

Australian researchers have found that zinc can 'starve' one of the world's most deadly bacteria by preventing its uptake of an essential metal.

11 Nov 2013

European Medicines Agency awards orphan drug designation to NanoViricides' DengueCide

NanoViricides, Inc. announced today that the European Medicines Agency, has awarded orphan drug designation to DengueCide, the Company's drug candidate for the treatment of dengue and dengue hemorrhagic fever.

11 Nov 2013

LSTM to celebrate 115 years of dedication in the field of tropical medicine

This Tuesday marks the 115th anniversary of the Liverpool School of Tropical Medicine, the first institution of its kind in the world dedicated to research and teaching in the field of tropical medicine.

11 Nov 2013

Risk of dangerous bloodstream infections can be reduced in newborns with central venous catheters

A new study led by Johns Hopkins Children's Center investigators shows that clinicians can reduce the risk of dangerous bloodstream infections in newborns with central venous catheters by ending use of the device as soon as possible, rather than waiting for signs of infection.

11 Nov 2013

Researchers launch clinical trial of investigational vaccine designed to prevent genital herpes disease

Researchers have launched an early-stage clinical trial of an investigational vaccine designed to prevent genital herpes disease. The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, is sponsoring the Phase I trial, which is being conducted at the NIH Clinical Center in Bethesda, Md.

11 Nov 2013

Infectious Diseases News and Research

Genetic mutations in parasite cause over 100 million cases of malaria annually in Africa

Mass. Eye and Ear's OGSH launches new collaboration to care for people ENT diseases

New Malaria Vaccine Technology Roadmap aims to identify second generation malaria vaccines

Scientists identify genetic signature of respiratory syncytial virus

Lower doses of antimalarial drug effective in reducing malaria transmission

Research may explain why people who take bone-strengthening drugs are at-risk for atypical fractures

HIVMA's updated HIV care guidelines show doctors should focus on common health conditions

Identifying 'sensome' of microglia could improve treatments for neurodegenerative disorders

Dermalogix awarded SBIR Phase II grant to develop topical drug candidate for atopic dermatitis

Diagnosing influenza with rapid tests leads to more efficient care

TAILORED-Treatment project to increase effectiveness of antibiotics receives EU funding

immatics, Roche enter into cancer vaccine and immunotherapy deal

New biomedical instrument anticipated to help breakthroughs in animal, human health

Infection prevention: an interview with Dr. Robert Gorab, Chief Medical Officer, Hoag Orthopedic Institute

Researchers discover new pathway for treating allergic diseases

Researchers find zinc starves bacteria by preventing its uptake of essential metal

European Medicines Agency awards orphan drug designation to NanoViricides' DengueCide

LSTM to celebrate 115 years of dedication in the field of tropical medicine

Risk of dangerous bloodstream infections can be reduced in newborns with central venous catheters

Researchers launch clinical trial of investigational vaccine designed to prevent genital herpes disease

Industry Focus eBook - Infectious Diseases (3rd Edition) eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News